[1]
“Efficacy of the Rho-kinase Inhibitor Ripasudil for Fuchs’ Endothelial Corneal Dystrophy”, jor, vol. 4, no. 3, pp. 231–243, Aug. 2021, Accessed: Sep. 21, 2026. Available: https://fortunejournals.org/ojs/index.php/jor/article/view/17409